Keywords: Merck Serono, Merck KGaA, Ablynx, Nanobodies, Osteoarthritis

Merck Serono expands osteoarthritis collaboration with Ablynx

Article | 09 November 2011

Print This

Merck Serono, a division of Germany’s Merck KGaA (MRK: DE) has entered into a third agreement with Ablynx ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in